Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 13, 2020Journal of Cosmetic Dermatology

Botulinum toxin type A attenuates hypertrophic scar formation via the inhibition of TGF‐β1/Smad and ERK pathways

View Full Paper
Ask AI
Bookmark
Share

Authors

YLY Y LiJYJiaomei YangZZZhao Zheng

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Li et al. (2020) studied this question.

synapsesocial.com/papers/6a7d4d9ce6f633beba6e554dhttps://doi.org/10.1111/jocd.13842
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Botulinum Neurotoxins: Biology, Pharmacology, and Toxicology2017 · 766 citations
  2. 2TGF-β1 is Involved in Vitamin D-Induced Chondrogenic Differentiation of Bone Marrow-Derived Mesenchymal Stem Cells by Regulating the ERK/JNK Pathway2017 · 36 citations
  3. 3Early Postoperative Application of Botulinum Toxin Type A Prevents Hypertrophic Scarring after Epicanthoplasty: A Split-Face, Double-Blind, Randomized Trial2019 · 56 citations
  4. 4The Safety and efficacy of botulinum toxin type A injection for postoperative scar prevention: A systematic review and meta‐analysis2019 · 26 citations